Alumis ALMS
NASDAQ ALMS
$6.78 -0.04 (-0.59%)
At close: Oct 23, 2026 · 4:00 PM EDT

Alumis (ALMS) Net Income (2023 - 2026)

Updated

Alumis (ALMS) posted Net Income of -$142.18 million for Q2 2026, compared with $59.36 million a year earlier.

Analysis

Alumis (ALMS) Net Income (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Income at Alumis was -$286.5 million; for FY2025, it came in at -$243.29 million.

  • In prior years, Alumis' Net Income was -$294.23 million in FY2024 and -$158.17 million in FY2023.
  • The Q2 2026 figure stands as the lowest quarterly Net Income in data going back to Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 210.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 3.62 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.51 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -10.50 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -248.00 Mn
10 Alumis 843.74 Mn -831.10 Mn - -142.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -142.18 Mn
Dec 31, 2025 -92.93 Mn
Sep 30, 2025 -110.75 Mn
Jun 30, 2025 59.32 Mn
Mar 31, 2025 -98.96 Mn
Dec 31, 2024 -94.76 Mn
Sep 30, 2024 -93.12 Mn
Jun 30, 2024 -56.51 Mn
Mar 31, 2024 -49.85 Mn
Dec 31, 2023 -39.30 Mn
Sep 30, 2023 -43.38 Mn
Jun 30, 2023 -36.71 Mn
API Access

Alumis Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=ALMS&period=max&api_key=YOUR_API_KEY